|
MPP6 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.423000E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.640500E-04 |
| Normal-vs-Stage2 |
7.377900E-02 |
| Normal-vs-Stage3 |
1.118600E-01 |
| Normal-vs-Stage4 |
3.705400E-01 |
| Stage1-vs-Stage2 |
6.987800E-01 |
| Stage1-vs-Stage3 |
3.005200E-01 |
| Stage1-vs-Stage4 |
3.670000E-01 |
| Stage2-vs-Stage3 |
3.462200E-01 |
| Stage2-vs-Stage4 |
3.449400E-01 |
| Stage3-vs-Stage4 |
8.925600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.233100E-04 |
| Normal-vs-AfricanAmerican |
8.815400E-01 |
| Normal-vs-Asian |
4.097800E-01 |
| Caucasian-vs-AfricanAmerican |
1.642360E-01 |
| Caucasian-vs-Asian |
9.370800E-01 |
| AfricanAmerican-vs-Asian |
4.739000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.000800E-01 |
| Normal-vs-Female |
3.25240000043081E-07 |
| Male-vs-Female |
1.68560999999068E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.116400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.206210E-02 |
| Normal-vs-Age(61-80Yrs) |
1.499000E-03 |
| Normal-vs-Age(81-100Yrs) |
2.566800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.887840E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.206790E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.219800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.001200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.898800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.138800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.160800E-01 |
| Normal-vs-Grade 2 |
2.160500E-03 |
| Normal-vs-Grade 3 |
3.229200E-04 |
| Normal-vs-Grade 4 |
2.769000E-01 |
| Grade 1-vs-Grade 2 |
5.498200E-01 |
| Grade 1-vs-Grade 3 |
4.264000E-01 |
| Grade 1-vs-Grade 4 |
3.997000E-01 |
| Grade 2-vs-Grade 3 |
4.775600E-01 |
| Grade 2-vs-Grade 4 |
1.355470E-03 |
| Grade 3-vs-Grade 4 |
2.447600E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.13520304267922E-11 |
| Normal-vs-ccB subtype |
4.481800E-01 |
| ccA subtype-vs-ccB subtype |
1.8960999437212E-10 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.581000E-04 |
| Normal-vs-N1 |
9.259200E-01 |
| N0-vs-N1 |
3.153000E-01 |
|
|
